Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

(2017) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease

(2015) E. Shelton et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease

(2014) E. Gizard et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)

(2014) C. Loras et al.   Journal of Crohns & Colitis

Hepatitis B vaccination in patients with inflammatory bowel disease

(2014) Ruwaida Ben Musa   WORLD JOURNAL OF GASTROENTEROLOGY

Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases

(2013) A. Douros et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Kinetics of Anti–Hepatitis B Surface Antigen Titers After Hepatitis B Vaccination in Patients With Inflammatory Bowel Disease

(2013) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Safety of Thiopurine Therapy in Inflammatory Bowel Disease

(2013) María Chaparro et al.   INFLAMMATORY BOWEL DISEASES

Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease

(2012) Achuthan Sourianarayanane et al.   Journal of Crohns & Colitis

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

(2011) Elaine Toy et al.   BMC GASTROENTEROLOGY

Incidence of Liver Toxicity in Inflammatory Bowel Disease Patients Treated with Methotrexate: A Meta-Analysis of Clinical Trials

(2011) Nabeel Khan et al.   INFLAMMATORY BOWEL DISEASES

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

(2010) C. Loras et al.   GUT

Pancreatitis in Inflammatory Bowel Diseases

(2010) C. S. Pitchumoni et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2009) J.F. Rahier et al.   Journal of Crohns & Colitis

Eficacia de la vacuna contra el virus de la hepatitis B en pacientes con enfermedad inflamatoria intestinal

(2009) Luis Vida Pérez et al.   MEDICINA CLINICA

Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis

(2008) F. BERMEJO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

(2008) Carme Loras et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

High lifetime risk of cancer in primary sclerosing cholangitis

(2008) Marian M.H. Claessen et al.   JOURNAL OF HEPATOLOGY